Clinical Features of VITT | NEJM
BNT162b2 Covid-19 Vaccine in 5-to-11-Year-Old Children | NEJM
Adagrasib in <i>KRAS<sup>G12C</sup></i>-Mutated Lung Cancer | NEJM
Comparative Effectiveness of mRNA Covid-19 Vaccines | NEJM
Angiotensin Receptor–Neprilysin Inhibition in Acute MI | NEJM
Tranexamic Acid in Noncardiac Surgery | NEJM
Intravenous Vitamin C for Sepsis in the ICU | NEJM
Once-Weekly Tirzepatide for Obesity | NEJM
Trastuzumab Deruxtecan for Breast Cancer | NEJM
Fourth Dose of BNT162b2 Covid-19 Vaccine | NEJM
IV Fluid Restriction in Septic Shock | NEJM
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer | NEJM
Early Ivermectin for Covid-19 | NEJM
Oral Molnupiravir to Treat Mild-to-Moderate Covid-19 | NEJM
Balanced Multielectrolyte Solution vs. Saline in ICUs | NEJM
Effectiveness of Covid-19 Vaccine in Adolescents | NEJM
CV and Cancer Risk with Tofacitinib in RA | NEJM
Ibrutinib for Untreated Mantle-Cell Lymphoma | NEJM
Lenacapavir in Multidrug-Resistant HIV-1 Infection | NEJM
NVX-CoV2373 Covid-19 Vaccine | NEJM
Oncolytic Virus for Pediatric Pontine Glioma | NEJM
Sotrovimab for Early Covid-19 | NEJM
Ublituximab in Relapsing Multiple Sclerosis | NEJM
Tirzepatide versus Semaglutide for Type 2 Diabetes | NEJM
